|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn942588114 |
003 |
OCoLC |
005 |
20231120112056.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
160302s2016 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d YDXCP
|d OPELS
|d N$T
|d COO
|d OCLCF
|d CDX
|d EBLCP
|d GGVRL
|d OCLCQ
|d WYU
|d OCLCQ
|d LVT
|d OCLCO
|d OCLCQ
|
066 |
|
|
|c (S
|
019 |
|
|
|a 945611935
|a 956735849
|a 1066621280
|a 1229344232
|
020 |
|
|
|a 9780128028858
|q (electronic bk.)
|
020 |
|
|
|a 0128028858
|q (electronic bk.)
|
020 |
|
|
|z 9780128028513
|q (print)
|
020 |
|
|
|a 0128028513
|
020 |
|
|
|a 9780128028513
|
035 |
|
|
|a (OCoLC)942588114
|z (OCoLC)945611935
|z (OCoLC)956735849
|z (OCoLC)1066621280
|z (OCoLC)1229344232
|
050 |
|
4 |
|a RC523
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8/31
|2 23
|
245 |
0 |
0 |
|a Genes, environment and Alzheimer's disease /
|c edited by Orly Lazarov, Giuseppina Tesco.
|
264 |
|
1 |
|a London, UK :
|b Academic Press is an imprint of Elsevier,
|c 2016.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed March 9, 2016).
|
504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
505 |
0 |
|
|a Front Cover; Genes, Environment and Alzheimer's Disease; Copyright Page; Contents; List of Contributors; Foreword; Preface; Introduction; 1 Molecular Mechanisms of Learning and Memory; From Plato's Wax Tablet to Genes; Memory Processes; Brain Structures Underlying Memory Processes; Cellular Basis of Memory; The Role of CREB in Memory; Pathways Activating CREB; HDACs/HATs Role in Gene Transcription; References; 2 When Cognitive Decline Becomes Pathology: From Normal Aging to Alzheimer's Disease; Models of Cognitive Decline in Healthy Aging
|
505 |
8 |
|
|a Distinguishing AD-Associated Cognitive Decline from Normal AgingDistinguishing Preclinical AD from Normal Aging with Event-Related Potentials (ERPs); Memory Deficits in Preclinical AD; Deficits in Associative Memory; Deficits in Pattern Separation; Deficits in Recollection and Familiarity; Deficits in Prospective Memory; Deficits in Remote Memory; Deficits in Working Memory; Asymmetric Cognitive Decline in Preclinical AD; Summary and Conclusions; References; 3 Adult Neurogenesis and Cognitive Function: Relevance for Disorders Associated with Human Aging; Introduction
|
505 |
8 |
|
|a Identification and Characterization of Adult NeurogenesisDevelopment and Maturation of Adult-Born Neurons; Adult Mammalian Hippocampal Circuitry; Factors Affecting Adult Neurogenesis; Neurogenic Niche; Stress; Aging; Environmental Enrichment, Physical Activity, and Diet; Antidepressants and Mood-Stabilizing Treatments; Proposed Functions of Adult Neurogenesis; Pattern Separation; Other Aspects of Spatial and Contextual Memory; Regulation of Mood and the HPA-Axis; Neurogenesis, Hippocampal Dysfunction, and Alzheimer's Disease; Proteins Linked to FAD Regulate Neurogenesis
|
520 |
|
|
|a This volume explores the interplay between genetic and environmental risk factors in the induction of cognitive decline and the development of dementia-related diseases such as Alzheimer's.
|
650 |
|
0 |
|a Alzheimer's disease.
|
650 |
|
0 |
|a Alzheimer's disease
|x Molecular aspects.
|
650 |
|
0 |
|a Alzheimer's disease
|x Genetic aspects.
|
650 |
|
2 |
|a Alzheimer Disease
|0 (DNLM)D000544
|
650 |
|
6 |
|a Maladie d'Alzheimer.
|0 (CaQQLa)201-0114128
|
650 |
|
6 |
|a Maladie d'Alzheimer
|0 (CaQQLa)201-0114128
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0374959
|
650 |
|
6 |
|a Maladie d'Alzheimer
|0 (CaQQLa)201-0114128
|x Aspect g�en�etique.
|0 (CaQQLa)201-0377534
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Alzheimer's disease.
|2 fast
|0 (OCoLC)fst00806532
|
650 |
|
7 |
|a Alzheimer's disease
|x Genetic aspects.
|2 fast
|0 (OCoLC)fst00806543
|
650 |
|
7 |
|a Alzheimer's disease
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst00806550
|
700 |
1 |
|
|a Lazarov, Orly,
|e editor.
|
700 |
1 |
|
|a Tesco, Giuseppina,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Genes, environment and Alzheimer's disease.
|d Amsterdam, [Netherlands] : Academic Press, �2016
|h 425 pages
|z 9780128028513
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128028513
|z Texto completo
|
880 |
8 |
|
|6 505-00/(S
|a Methodologies for Studying Adult NeurogenesisLabeling Dividing and Maturing Cells; Manipulating Neurogenesis in Rodents; Human Technologies; Conclusion; References; I. Hallmarks and Genetic Forms of AD; 4 The Amyloid β Precursor Protein and Cognitive Function in Alzheimer's Disease; Introduction; The APP Gene and Its Homologs; The APP Protein, Its Domains, and Its Proteolytic Fragments; Intracellular Trafficking and Processing of APP; Cholesterol and APP Processing; APP-Interacting Proteins: Signal Transduction and Processing; Interactors with the YENPTY Motif
|
880 |
8 |
|
|6 505-00/(S
|a Low-Density Lipoprotein ReceptorsFunctions of APP; Neurogenesis: Embryonic and Adult; Neurite Outgrowth; Axonal Transport; Synaptic Formation and Function; Transcription Factor; Metal Binding/Redox; Does Aβ Have a Function?; APP Knockout Mice; APP and AD; Disrupted Axonal Transport; Disrupted Neurogenesis; Altered APP Processing/Translocation; Altered Signal Transduction; References; 5 Molecular Pathways in Alzheimer's Disease and Cognitive Function: New Insights into Pathobiology of Tau; Introduction; Normal Production and Function of Tau; Pathogenic Tau; Tau-Mediated Neuronal Deficits
|